Skip to content

Comparison of two methods of giving propofol and their effects on blood pressure during the start of general anaesthesia in adults undergoing planned non-heart surgery

Comparative evaluation of Marsh and Schnider pharmacokinetic models for propofol in terms of hemodynamic changes during induction of general anesthesia in adult patients scheduled for elective non-cardiac surgery a prospective randomised study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101296
Enrollment
200
Registered
2026-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Propofol target-controlled infusion using the Marsh pharmacokinetic mode: Propofol will be administered for induction of general anaesthesia using a target-controlled infusion (TCI) pum

Sponsors

Dr. VIKRAM SHILIGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between eighteen and sixty years Patients with American Society of Anesthesiologists physical status one or two Patients scheduled for elective non cardiac surgery under general anaesthesia Patients with body mass index between eighteen point five and thirty five kilograms per square metre Patients providing written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients with American Society of Anesthesiologists physical status three or higher Patients with known cardiovascular instability, such as cardiac rhythm disturbances, uncontrolled high blood pressure, or heart failure Patients with a history of difficult airway or those requiring rapid sequence induction Patients who have received central nervous system depressants or sedative medications within twenty four hours prior to surgery Patients with known allergy or hypersensitivity to propofol or related drugs Pregnant or breastfeeding women Patients with severe liver or kidney impairment Patients with neurological or psychiatric illness Patients who are unable to understand or cooperate with the study protocol

Design outcomes

Primary

MeasureTime frame
Percentage decrease in mean arterial blood pressure (MAP) during induction of general anaesthesia within the first ten minutes following endotracheal intubation.Timepoint: Baseline (prior to induction of anaesthesia) and at 1-minute intervals for 10 minutes following endotracheal intubation.

Secondary

MeasureTime frame
Total dose of propofol administered during induction, normalised for body weight Timepoint: NIL;Time taken to achieve induction of anaesthesia, defined as attainment of BIS value of 40Timepoint: NIL;Predicted effect-site concentration of propofol at the time of inductionTimepoint: NIL;Requirement of vasopressor support during induction of anaesthesiaTimepoint: NIL

Countries

India

Contacts

Public ContactDr VENKATESH S

SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH

venkymail2014@gmail.com9944731220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026